Oxcarbazepine: hyponatraemia and skin reactions.
A report from Novartis and an analysis of the French national database both confirm the adverse effect profile of oxcarbazepine, which includes potentially severe hyponatraemia and cutaneous disorders.
D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects* / Q000031:analogs & derivatives; D005602:France; D006801:Humans; D006967:Hypersensitivity; D007010:Hyponatremia / Q000139:chemically induced*
D000927:Anticonvulsants; D002220:Carbamazepine